Abstract
It is the familiar symptoms of sore throat, runny nose, sneezing, and nasal congestion, muscle aches, chilliness and fever, etc., that define the common cold and flu syndromes as self-diagnosed illnesses. Although there is much information about the molecular biology of the viruses that cause the common cold and flu syndromes, there is relatively little research on the immunological, physiological and pathophysiological mechanisms involved in generating the symptoms. This chapter studies the mechanisms that cause local symptoms associated with local inflammation of the airway (sore throat, sneezing, rhinorrhoea and purulent nasal discharge, nasal congestion, sinus pain, watery eyes and cough), and the mechanisms that cause systemic symptoms associated with release of cytokines from leukocytes (headache, chilliness and fever, psychological effects, malaise and mood changes, loss of appetite, and muscle aches and pains).
Chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Eccles R (2005) Understanding the symptoms of the common cold and influenza. Lancet Infect Dis 5: 718–725.
Jackson G, Dowling H, Spiesman I, Boand A (1958) Transmission of the common cold to volunteers under controlled conditions. 1. The common cold as a clinical entity. Arch Intern Med 101:267–278
Heikkinen T, Jarvinen A (2003) The common cold. Lancet 361:51–59.
Tyrrell DA, Cohen S, Schlarb JE (1993) Signs and symptoms in common colds. Epidemiol Infect 111: 143–156
Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J (2000) Clinical signs and symptoms predicting influenza infection. Arch Inter Med 160:3243–3247.
Schmid-Hempel P (2009) Immune defence, parasite evasion strategies and their relevance for ‘macroscopic phenomena’ such as virulence. Philos Trans R Soc Lond 364:85–98
Winther B, Farr B, Turner RB, Hendley JO, Gwaltney JM, Jr, Mygind N (1984) Histopathologic examination and enumeration of polymorphonuclear leukocytes in the nasal mucosa during experimental rhinovirus colds. Acta Otolaryngol Suppl 413: 19–24
Smith A, Thomas M, Kent J, Nicholson K (1998) Effects of the common cold on mood and performance. Psychoneuroendocrinology 23:733–739
Weiss RA (2002) Virulence and pathogenesis. Trends Microbiol 10:314–317
Eccles R (2005) Asymptomatic spread of flu is not proved. BMJ 331:1145
Turner RB, Hendley JO (2005) Virucidal hand treatments for prevention of rhinovirus infection. J Antimicrob Chemother 56:805–807
Turner RB (1997) Epidemiology, pathogenesis, and treatment of the common cold. Ann Allergy Asthma Immunol 78:531–539
Hendley JO (1998) The host response, not the virus, causes the symptoms of the common cold. Clin Infect Dis 26:847–848
Beutler B (2003) Science review: Key inflammatory and stress pathways in critical illness — The central role of the Toll-like receptors. Crit Care 7:39–46
Exton MS (1997) Infection-induced anorexia: active host defence strategy. Appetite 29:369–383
Eccles R (2000) Pathophysiology of nasal symptoms. Am J Rhinol 14:335–338
Proud D, Reynolds CJ, Lacapra S, Kagey-Sobotka A, Lichenstein LM, Naclerio RM (1988) Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat. Am Rev Respir Dis 173:613–616
Shibayama Y, Skoner D, Suehiro S, Konishi JE, Fireman P, Kaplan AP (1996) Bradykinin levels during experimental nasal infection with rhinovirus and attenuated influenza virus. Immunopharmacology 33:311–313
Conti B, Tabarean I, Andrei C, Bartfai T (2004) Cytokines and fever. Front Biosci 9:1433–1449
Georgitis JW (1993) Nasopharyngitis, pharyngitis, and tonsillitis. Immunol Allergy Clin North Am 13:109–118
Rees GL, Eccles R (1994) Sore throat following nasal and oropharyngeal bradykinin challenge. Acta Otolaryngol 114:311–314
Eccles R, Loose I, Jawad M, Nyman L (2003) Effects of acetylsalicylic acid on sore throat pain and other pain symptoms associated with acute upper respiratory tract infection. Pain Med 4:118–124
Eccles R (2006) Efficacy and safety of over-the-counter analgesics in the treatment of common cold and flu. J Clin Pharm Ther 31:309–319
Winther B, Gwaltney JM, Mygind N, Turner RB, Hendley O (1986) Sites of rhinovirus recovery after point inoculation of the upper airway. J Am Med Assoc 256:1763–1767
Leung AKC, Robson WLM (1994) Sneezing. J Otolaryngol 23:125–129
Mygind N, Secher C, Kirkegaard J (1983) Role of histamine and antihistamines in the nose. Eur J Respir Dis Suppl 128: 16–20
Askenasy JJM (1990) The photic sneeze. Postgrad Med J 66:892–893
Whitman BW, Packer RJ (1993) The photic sneeze: Literature review and discussion. Neurology 43:868–871
Hayden FG, Diamond L, Wood PB, Korts DC, Wecker MT (1996) Effectiveness and safety of intranasal ipratropium bromide in common colds. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 125:89–97
Eccles R, Vancauwenberge P, Tetzloff W, Borum P (1995) A clinical study to evaluate the efficacy of the antihistamine doxylamine succinate in the relief of runny nose and sneezing associated with upper respiratory-tract infection. J Pharm Pharmacol 47:990–993
Gwaltney JM, Winther B (1994) Symposium on rhinovirus pathogenesis. Acta Otolaryngol (Stockholm) Suppl 413: 45p
Eccles R (1983) Physiology of nasal secretion. Eur J Respir Dis 62:115–119
Eccles R, Pedersen A, Regberg D, Tulento H, Borum P, Stjarne P (2007) Efficacy and safety of topical combinations of ipratropium and xylometazoline for the treatment of symptoms of runny nose and nasal congestion associated with acute upper respiratory tract infection. Am J Rhinol 21:40–45
Murray S, Del Mar C, O’Rourke P (2000) Predictors of an antibiotic prescription by GPs for respiratory tract infections: A pilot. Fam Pract 17:386–388
Stockley RA, Bayley D, Hill SL, Hill AT, Crooks S, Campbell EJ (2001) Assessment of airway neutrophils by sputum colour: Correlation with airways inflammation. Thorax 56:366–372
Arroll B, Kenealy T (2005) Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database of Systematic Reviews (Online): CD000247
Davis SS, Eccles R (2004) Nasal congestion: Mechanisms, measurement and medications. Core information for the clinician. Clin Otolaryngol 29:659–666
Eccles R (2000) Nasal airflow in health and disease. Acta Otolaryngol (Stockholm) 120:580–595
Eccles R, Reilly M, Eccles KSJ (1996) Changes in the amplitude of the nasal cycle associated with symptoms of acute upper respiratory tract infection. Acta Otolaryngol 116:77–81
Malcolmson KG (1959) The vasomotor activities of the nasal mucous membrane. J Laryngol Otol 37:73–98
Eccles R (1983) Sympathetic control of nasal erectile tissue. Eur J Respir Dis 64:150–154
Lacroix JS, Stjarne P, Anggard A, Lundberg JM (1989) Sympathetic vascular control of the pig nasal mucosa (III): Co-release of noradrenaline and neuropeptide Y. Acta Physiol Scand 135:17–28
Eccles R, Eriksson M, Garreffa S, Chen SC (2008) The nasal decongestant effect of xylometazoline in the common cold. Am J Rhinol 22:491–496
Eccles R, Jawad MS, Angello JT, Druce HM (2005) Efficacy and safety of single and multiple doses of pseudoephedrine in the treatment of nasal congestion associated with common cold. Am J Rhinol 19:25–31
Clarke JD, Eccles R (2005) Paradoxical sensation of nasal airflow in patients with common cold. Are we measuring the correct modality? Acta Otolaryngol 125:1307–1311
Gwaltney JM, Phillips CD, Miller RD, Riker DK (1994) Computed tomographic study of the common cold. N Engl J Med 330:25–30
Falck B, Svanholm H, Aust R, Backlund L (1989) The relationship between body posture and pressure in occluded maxillary sinus of man. Rhinology 27: 161–167
Whittet HB (1992) Infraorbital nerve dehiscence: The anatomic cause of maxillary sinus “vacuum headache”? Otolaryngol Head Neck Surg 107:21–28
Falck B, Svanholm H, Aust R, Backlund L (1990) Blood flow and pulse amplitude in the mucosa of the human maxillary sinus in relation to body posture. Rhinology 28:169–176
Ayub M, Thale AB, Hedderich J, Tillmann BN, Paulsen FP (2003) The cavernous body of the human efferent tear ducts contributes to regulation of tear outflow. Invest Ophthalmol Vis Sci 44:4900–4907
Paulsen F, Hallmann U, Paulsen J, Thale A (2000) Innervation of the cavernous body of the human efferent tear ducts and function in tear outflow mechanism. J Anat 197:177–187
Hadjikoutis S, Eccles R, Wiles CM (2000) Coughing and choking in motor neuron disease. J Neurol Neurosurg Psychiatry 68:601–604
Eccles R, Lee PC (2004) Cough induced by airway vibration as a model of airway hyperreactivity in patients with acute upper respiratory tract infection. Pulm Pharmacol Ther 17:337–342
Jacoby DB (2004) Pathophysiology of airway viral infections. Pulm Pharmacol Ther 17:333–336
Lee P, Cotterill-Jones C, Eccles R (2002) Voluntary control of cough. Pulm Pharmacol Ther 15:317–320
Davenport PW (2008) Urge-to-cough: What can it teach us about cough? Lung 186 (Suppl 1):S107–111
Widdicombe J, Eccles R, Fontana G (2006) Supramedullary influences on cough. Respir Physiol Neurobiol 152:320–328
Simonyan K, Saad ZS, Loucks TM, Poletto CJ, Ludlow CL (2007) Functional neuroanatomy of human voluntary cough and sniff production. Neuro Image 37:401–409
Hutchings HA, Eccles R, Smith AP, Jawad M (1993) Voluntary cough suppression as an indication of symptom severity in upper respiratory tract infections. Eur Respir J 6:1449–1454
Hutchings HA, Morris S, Eccles R, Jawad M (1993) Voluntary suppression of cough induced by inhalation of capsaicin in healthy volunteers. Respir Med 87: 379–382
Eccles R (2006) Mechanisms of the placebo effect of sweet cough syrups. Respir Physiol Neurobiol 152:340–348
Smith RS (1992) The cytokine theory of headache. Med Hypotheses 39:168–174
Gold R, Rieckmann P, Chang P, Abdalla J (2005) The long-term safety and tolerability of high-dose interferon beta-1a in relapsing-remitting multiple selerosis: 4-year data from the PRISMS study. Eur J Neurol 12:649–656
van Zonneveld M, Flink HJ, Verhey E, Senturk H, Zeuzem S, Akarca US, Cakaloglu Y, Simon C, So TM, Gerken G et al. (2005) The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: Predictive factors for dose reduction and treatment discontinuation. Aliment Pharmacol Ther 21: 1163–1171
Bo SH, Davidsen EM, Gulbrandsen P, Dietrichs E, Bovim G, Stovner LJ, White LR (2009) Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache. Cephalalgia 29:365–372
Helman CG (1978) “Feed a cold, starve a fever”. Folk models of infection in an English suburban community, and their relation to medical treatment. Cult Med Psychiatry 2:107–137
Sanu A, Eccles R (2008) The effects of a hot drink on nasal airflow and symptoms of common cold and flu. Rhinology 46:271–275
Guieu JD, Hellon RF (1980) The chill sensation in fever. Pflugers Arch 384: 103–104
Cabanac M (1990) Phylogeny of fever. In: J Bligh, K Voigt (eds): Thermoreception and temperature regulation. Springer, Berlin, 284–296
Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA, Walmsley SL, Mazzulli T, Avendano M, Derkach P et al. (2003) Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 289:2801–2809
Leon LR (2002) Invited review: Cytokine regulation of fever: Studies using gene knockout mice. J Appl Physiol 92:2648–2655
Netea MG, Kullberg BJ, Van der Meer JW (2000) Circulating cytokines as mediators of fever. Clin Infect Dis 31 (Suppl 5): S178–184
Blatteis CM (2007) The onset of fever: New insights into its mechanism. Prog Brain Res 162:3–14
Dantzer R, Kelley KW (2007) Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 21:153–160
Vollmer-Conna U, Fazou C, Cameron B, Li H, Brennan C, Luck L, Davenport T, Wakefield D, Hickie I, Lloyd A (2004) Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans. Psychological Medicine 34:1289–1297
Herzog C, Berger R, Fernex M, Friesecke K, Havas L, Just M, Dubach UC (1986) What dose of intranasal interferon for the common cold? Lancet 1: 1089–1090
Gwaltney JM, Jr, Winther B, Patrie JT, Hendley JO (2002) Combined antiviralantimediator treatment for the common cold. J Infect Dis 186:147–154
Schaefer M, Schmidt F, Neumer R, Scholler G, Schwarz M (2002) Interferonalpha, cytokines and possible implications for mood disorders. Bipolar Disord 4 (Suppl 1):111–113
Miller AH (2009) Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface. Brain Behav Immun 23:149–158
Raison CL, Borisov AS, Majer M, Drake DF, Pagnoni G, Woolwine BJ, Vogt CJ, Massung B, Miller AH (2009) Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression. Biol Psychiatry 65:296–303
McCarthy DO (2000) Cytokines and the anorexia of infection: Potential mechanisms and treatments. Biol Res Nurs 1:287–298
Brobeck JR (1948) Food intake as a mechanism of temperature regulation. Yale J Biol Med 20:545–552
Mahoney T, Ball P (2002) Common respiratory tract infections as psychological entities: A review of the mood and performance effects of being ill. Aust Psychol 37:86–94
Baracos V, Rodemann HP, Dinarello CA, Goldberg AL (1983) Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever. N Engl J Med 308:553–558
Kotler DP (2000) Cachexia. Ann Intern Med 133:622–634
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Birkhäuser Verlag Basel/Switzerland
About this chapter
Cite this chapter
Eccles, R. (2009). Mechanisms of symptoms of common cold and flu. In: Eccles, R., Weber, O. (eds) Common Cold. Birkhäuser Advances in Infectious Diseases. Birkhäuser Basel. https://doi.org/10.1007/978-3-7643-9912-2_2
Download citation
DOI: https://doi.org/10.1007/978-3-7643-9912-2_2
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-7643-9894-1
Online ISBN: 978-3-7643-9912-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)